Research and Markets (http://www.researchandmarkets.com/research/l7fp8z/medullary_thyroid) has announced the addition of the "Medullary Thyroid Cancer-Pipeline Insights, 2016" report to their offering.

Medullary Thyroid Cancer-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Medullary Thyroid Cancer. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Medullary Thyroid Cancer.

The report also assesses the Medullary Thyroid Cancer therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

  • The report provides competitive pipeline landscape of Medullary Thyroid Cancer
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Medullary Thyroid Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Medullary Thyroid Cancer and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  1. Medullary Thyroid Cancer Overview
  2. Medullary Thyroid Cancer Pipeline Therapeutics
  3. Medullary Thyroid Cancer Therapeutics under Development by Companies
  4. Medullary Thyroid Cancer Filed and Phase III Products
  5. Comparative Analysis
  6. Medullary Thyroid Cancer Phase II Products
  7. Medullary Thyroid Cancer Phase I and IND Filed Products
  8. Medullary Thyroid Cancer Discovery and Pre-Clinical Stage Products
  9. Medullary Thyroid Cancer - Therapeutics Assessment
  10. Assessment by Monotherapy Products
  11. Assessment by Combination Products
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Medullary Thyroid Cancer - Discontinued Products
  15. Medullary Thyroid Cancer - Dormant Products
  16. Companies Involved in Therapeutics Development for Medullary Thyroid Cancer

For more information visit http://www.researchandmarkets.com/research/l7fp8z/medullary_thyroid